Ballard Wright, MD, PSC
Ballard Wright, MD, PSC was paid $12.39M by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is G0480, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed — 35% of everything it billed.
LEXINGTON, KY 40503
Next to other Clinical Social Worker providers in Kentucky
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 77,169 | $2.59M | |
| 2019 | 61,915 | $2.11M | |
| 2020 | 48,749 | $1.52M | |
| 2021 | 61,212 | $1.85M | |
| 2022 | 53,697 | $1.49M | |
| 2023 | 62,860 | $1.64M | |
| 2024incomplete | 38,321 | $1.19M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 35% | 66,754 | 62,520 | $4.37M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 24% | 72,065 | 67,399 | $2.95M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 89,796 | 79,609 | $1.94M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 42,450 | 36,679 | $1.51M |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 2.7% | 6,489 | 5,477 | $332K |
| 99490 | Ccm add 20min | 2.3% | 14,484 | 13,424 | $285K |
| 80053 | Comprehensive metabolic panel | 1.2% | 19,892 | 18,810 | $144K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19,934 | 18,849 | $110K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 1,924 | 1,715 | $102K |
| 82977 | <1% | 19,902 | 18,851 | $102K | |
| 64635 | <1% | 532 | 395 | $72K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,549 | 1,298 | $67K |
37 more codes
| 82248 | <1% | 12,119 | $42K | |
| 84100 | <1% | 12,140 | $40K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 1,605 | $34K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 412 | $31K |
| 99439 | <1% | 1,175 | $27K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,391 | $26K |
| 64636 | <1% | 519 | $25K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,002 | $20K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 496 | $19K |
| 77080 | <1% | 301 | $17K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,575 | $16K |
| 64483 | <1% | 91 | $12K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,079 | $11K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 765 | $11K |
| 64493 | <1% | 132 | $10K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 372 | $10K |
| 96127 | <1% | 2,061 | $10K | |
| 86328 | <1% | 308 | $9K | |
| G0659 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes | <1% | 145 | $9K |
| 97162 | <1% | 213 | $6K | |
| 64494 | <1% | 132 | $6K | |
| 99152 | <1% | 769 | $6K | |
| 62323 | <1% | 89 | $4K | |
| 96160 | <1% | 856 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 14 | $2K |
| 97164 | <1% | 83 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 15 | $1K |
| 90836 | <1% | 49 | $1K | |
| 80050 | General health panel | <1% | 16 | $782.88 |
| 72100 | <1% | 45 | $594.67 | |
| 20552 | <1% | 17 | $350.57 | |
| 99442 | <1% | 19 | $309.85 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 50 | $240.64 |
| 84403 | <1% | 12 | $226.80 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 25 | $185.87 |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 47 | $100.47 |
| 99441 | <1% | 13 | $92.19 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.